Our breast pathology services provide timely, expert evaluation of breast tissue specimens, delivering precise and clinically actionable results. We utilize ancillary techniques, including immunohistochemistry for biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and HER2, as well as additional molecular studies when appropriate, to further characterize tumors and guide targeted therapy decisions. These critical insights help determine prognosis and support personalized treatment strategies.

With an emphasis on diagnostic accuracy and timely turnaround, our breast pathology services play a central role in multidisciplinary breast care, supporting clinicians in delivering the best possible outcomes for patients.